IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Cellular oncology (Dordrecht)

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on October 31, 2023

Impact Score

2022-2023

6.31

h-Index

2022-2023

 53

Rank

2022-2023

 2361

SJR

2022-2023

 1.408

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Cellular oncology (Dordrecht)
Abbreviation Cell. oncol. (Dordr.)
Publication Type Journal
Subject Area, Categories, Scope Medicine (miscellaneous) (Q1); Molecular Medicine (Q1); Oncology (Q1); Cancer Research (Q2)
h-index 53
Overall Rank/Ranking 2361
SCImago Journal Rank (SJR) 1.408
Impact Score 6.31
Publisher Springer Netherlands
Country Netherlands
ISSN 22113436, 22113428
Best Quartile Q1
Coverage History 2011-2022




About Cellular oncology (Dordrecht)


Cellular oncology (Dordrecht) is a journal covering the technologies/fields/categories related to Medicine (miscellaneous) (Q1); Molecular Medicine (Q1); Oncology (Q1); Cancer Research (Q2). It is published by Springer Netherlands. The overall rank of Cellular oncology (Dordrecht) is 2361. According to SCImago Journal Rank (SJR), this journal is ranked 1.408. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 53. The best quartile for this journal is Q1.

The ISSN of Cellular oncology (Dordrecht) journal is 22113436, 22113428. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Cellular oncology (Dordrecht) is cited by a total of 1408 articles during the last 3 years (Preceding 2022).


Cellular oncology (Dordrecht) Impact IF 2022-2023


The Impact IF 2022 of Cellular oncology (Dordrecht) is 6.31, which is computed in 2023 as per its definition. Cellular oncology (Dordrecht) IF is decreased by a factor of 0.43 and approximate percentage change is -6.38% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Cellular oncology (Dordrecht) Impact IF 2023 Prediction


Impact IF 2022 of Cellular oncology (Dordrecht) is 6.31. If the same downward trend persists, Impact IF may fall in 2023 as well.


Impact IF Trend


Year wise Impact IF of Cellular oncology (Dordrecht). Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2022 6.31
2021 6.74
2020 6.10
2019 5.00
2018 5.15
2017 4.84
2016 4.33
2015 4.11
2014 3.62

Cellular oncology (Dordrecht) h-index


  Table Setting

Cellular oncology (Dordrecht) has an h-index of 53. It means 53 articles of this journal have more than 53 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Cellular oncology (Dordrecht) ISSN


The ISSN of Cellular oncology (Dordrecht) is 22113436, 22113428. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Cellular oncology (Dordrecht) Rank and SCImago Journal Rank (SJR)


The overall rank of Cellular oncology (Dordrecht) is 2361. According to SCImago Journal Rank (SJR), this journal is ranked 1.408. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Cellular oncology (Dordrecht) by Year


Year SJR
2023/2024 Coming Soon
2022 1.408
2021 1.326
2020 1.698
2019 1.271
2018 1.457
2017 1.465
2016 1.199
2015 1.479
2014 1.328

Ranking of Cellular oncology (Dordrecht) by Year


Year Ranking
2023/2024 Coming Soon
2022 2361
2021 2595
2020 1810
2019 2972
2018 2369
2017 2398
2016 3354
2015 2441
2014 2816

Cellular oncology (Dordrecht) Publisher


Table Setting

Cellular oncology (Dordrecht) is published by Springer Netherlands. It's publishing house is located in Netherlands. Coverage history of this journal is as following: 2011-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Cellular oncology (Dordrecht) is Cell. oncol. (Dordr.). This abbreviation ('Cell. oncol. (Dordr.)') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Cellular oncology (Dordrecht)


If your research field is/are related to Medicine (miscellaneous) (Q1); Molecular Medicine (Q1); Oncology (Q1); Cancer Research (Q2), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Cellular oncology (Dordrecht)?

Cellular oncology (Dordrecht) latest impact IF is 6.31. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 6.74 (2021) and 3.62 (2014), respectively, in the last 9 years. Moreover, its average IS is 5.13 in the previous 9 years.


What's the SCImago Journal Rank (SJR) of the Cellular oncology (Dordrecht)?

The Cellular oncology (Dordrecht) has an SJR (SCImago Journal Rank) of 1.408, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 1.698 in 2020 and the lowest being 1.199 in 2016. Furthermore, the average SJR of the Cellular oncology (Dordrecht) over the previous 9-year period stands at 5.13.


What's the latest h-index of the Cellular oncology (Dordrecht)?

The latest h-index of the Cellular oncology (Dordrecht) is 53.


Who's the publisher of the Cellular oncology (Dordrecht)?

The Cellular oncology (Dordrecht) is published by the Springer Netherlands, with its country of publication being the Netherlands.


What's the current ranking of the Cellular oncology (Dordrecht)?

The Cellular oncology (Dordrecht) is currently ranked 2361 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 1810 in 2020 and its lowest position of 3354 in 2016.


What's the abbreviation or short name for the Cellular oncology (Dordrecht)?

The standard ISO4 abbreviation for the Cellular oncology (Dordrecht) is Cell. oncol. (Dordr.).


Is the "Cellular oncology (Dordrecht)" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Cellular oncology (Dordrecht) is classified as a journal that the Springer Netherlands publishes.


What's the scope or major areas of the Cellular oncology (Dordrecht)?

The Cellular oncology (Dordrecht) encompasses the following areas:

  • Medicine (miscellaneous)
  • Molecular Medicine
  • Oncology
  • Cancer Research

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Cellular oncology (Dordrecht)?

The Cellular oncology (Dordrecht) is assigned the following International Standard Serial Numbers (ISSN): 22113436, 22113428.


What's the best quartile of the Cellular oncology (Dordrecht)?

The best quartile for the Cellular oncology (Dordrecht) is Q1 (2022).


What's the coverage history of the Cellular oncology (Dordrecht)?

The Cellular oncology (Dordrecht) coverage history can be summarized as follows: 2011-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Dermatologia Kliniczna journal 25442 Cornetis 7 0.00
Journal of Academic Ethics journal 8920 Springer Netherlands 26 2.28
Journal of International Financial Management and Accounting journal 6179 Wiley-Blackwell Publishing Ltd 42 6.09
Oral Radiology journal 9461 Springer Japan 20 2.06
Epigenetics journal 2362 Landes Bioscience 105 4.11
Journal of Immigrant and Refugee Studies journal 9246 Routledge 32 1.46
Proteomics - Clinical Applications journal 9140 Wiley-VCH Verlag 59 2.02
Proceedings of the Royal Society of Queensland journal 22998 Royal Society of Queensland 12 0.48
SPE International Formation Damage Control Symposium Proceedings conference and proceedings 21934 16 0.00
Physics and Chemistry of the Earth journal 12927 Pergamon Press Ltd. 33 0.00

Check complete list




Year wise Impact Score (IS) of Cellular oncology (Dordrecht)

Impact Score Table

Year Impact Score (IS)
2023/2024 Coming Soon
2022 6.31
2021 6.74
2020 6.10
2019 5.00
2018 5.15
2017 4.84
2016 4.33
2015 4.11
2014 3.62



Top Journals/Conferences in Medicine (miscellaneous)

New England Journal of Medicine
Massachussetts Medical Society | United States

Nature Medicine
Nature Publishing Group | United Kingdom

MMWR Recommendations and Reports
Centers for Disease Control and Prevention (CDC) | United States

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Nature Reviews Immunology
Nature Publishing Group | United Kingdom

Morbidity and Mortality Weekly Report
Department of Health and Human Services | United States

Lancet, The
Elsevier Ltd. | United Kingdom

Physiological Reviews
American Physiological Society | United States

MMWR supplements
Epidemiology Program Office | United States

Annals of Oncology
Elsevier Ltd. | United Kingdom

See All

Top Journals/Conferences in Molecular Medicine

Nature Biotechnology
Nature Publishing Group | United Kingdom

Cell Stem Cell
Cell Press | United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

Pharmacological Reviews
American Society for Pharmacology and Experimental Therapeutics | United States

Genome Medicine
BioMed Central Ltd. | United Kingdom

EMBO Molecular Medicine
Wiley-Blackwell | United Kingdom

Molecular Therapy
Cell Press | United States

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

Experimental and Molecular Medicine
Korean Society of Med. Biochemistry and Mol. Biology | South Korea

Molecular Aspects of Medicine
Elsevier Ltd. | United Kingdom

See All

Top Journals/Conferences in Oncology

Ca-A Cancer Journal for Clinicians
Wiley-Blackwell | United States

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Nature Reviews Clinical Oncology
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Lancet Oncology, The
Elsevier Ltd. | United Kingdom

Annals of Oncology
Elsevier Ltd. | United Kingdom

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Nature Cancer
| United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

JAMA Oncology
American Medical Association | United States

See All

Top Journals/Conferences in Cancer Research

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Cell Host and Microbe
Cell Press | United States

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Nature Cancer
| United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

JAMA Oncology
American Medical Association | United States

Signal Transduction and Targeted Therapy
Springer Nature | United Kingdom

Journal of Hematology and Oncology
BioMed Central Ltd. | United Kingdom

Journal of the National Cancer Institute
Oxford University Press | United Kingdom

See All